Photo
Language
English
Title and Department
Assistant Professor of Medicine, Department of Medicine, Division of Hematology and Oncology
Assistant Professor, Department of Pathology, Microbiology, and Immunology
Professional bio
Mary Philip, MD, PhD is an Assistant Professor of Medicine in the Division of Hematology and Oncology. Se is also an Assistant Professor of Medicine in the Department of Pathology, Microbiology and Immunology.
Dr. Philip received her BS in Molecular Biophysics and Biochemistry from Yale University and her MD and PhD in cancer biology from the University of Chicago. Her thesis work in the laboratory of Dr. Hans Schreiber uncovered new mechanisms of tumor-specific antigen generation and presentation to T cells. She completed Internal Medicine Residency training at the University of Chicago before going to the Fred Hutchinson Cancer Research Center/University of Washington in Seattle for Hematology/Oncology fellowship training. There she received a NCI K08 career development award and an American Society of Hematology Scholar Award for her research in Dr. Janis Abkowitz’s lab on metabolic regulation of T cell development. Dr. Philip built on her knowledge of T cell differentiation to decipher mechanisms of T cell dysfunction in solid tumors after joining Dr. Andrea Schietinger’s group at Memorial Sloan Kettering Cancer Center. Her studies on how epigenetic programs define T cell dysfunction and therapeutic reprogramming in solid tumors were recently published in Nature (2017). Her clinical training and work has shaped and informed her laboratory research, and she would like to build on her strengths in cancer immunology and hematologic malignancies to care for patients undergoing hematopoietic stem cell transplant and/or immunotherapy. As a laboratory-based investigator and physician-scientist, Dr. Philip’s goal is to use clinically-relevant, cutting-edge mouse models of cancer to tackle important cancer immunology questions and to design more potent and safer immunotherapy strategies for cancer patients.
Dr. Philip received her BS in Molecular Biophysics and Biochemistry from Yale University and her MD and PhD in cancer biology from the University of Chicago. Her thesis work in the laboratory of Dr. Hans Schreiber uncovered new mechanisms of tumor-specific antigen generation and presentation to T cells. She completed Internal Medicine Residency training at the University of Chicago before going to the Fred Hutchinson Cancer Research Center/University of Washington in Seattle for Hematology/Oncology fellowship training. There she received a NCI K08 career development award and an American Society of Hematology Scholar Award for her research in Dr. Janis Abkowitz’s lab on metabolic regulation of T cell development. Dr. Philip built on her knowledge of T cell differentiation to decipher mechanisms of T cell dysfunction in solid tumors after joining Dr. Andrea Schietinger’s group at Memorial Sloan Kettering Cancer Center. Her studies on how epigenetic programs define T cell dysfunction and therapeutic reprogramming in solid tumors were recently published in Nature (2017). Her clinical training and work has shaped and informed her laboratory research, and she would like to build on her strengths in cancer immunology and hematologic malignancies to care for patients undergoing hematopoietic stem cell transplant and/or immunotherapy. As a laboratory-based investigator and physician-scientist, Dr. Philip’s goal is to use clinically-relevant, cutting-edge mouse models of cancer to tackle important cancer immunology questions and to design more potent and safer immunotherapy strategies for cancer patients.